UCSF home page UCSF home page About UCSF Search UCSF UCSF Medical Center
UCSF navigation bar
banner
HRPP LOGO
For New Investigators For Researchers
and Staff
Committee on Human Research About the Committee
phone

Contact Information

Organization

Applying to the CHR Applying & Reporting to the CHR
forms and templates Applications & Forms
Recruitment and Consent Process Recruitment & Consent Process
policies and guidelines UCSF Guidance on Research Topics & Issues
Veterans Affairs Medical Center Logo Working With the VA
Working with Other Institutions and Units Working With Other Institutions & Units
For Research Volunteers For Research Volunteers
quality improvement unit About the Quality Improvement Unit (QIU)
Education & Training
Status Checks and Research Online Status Checks & Research Online
HIPAA and Research HIPAA & Research
Federal Regulations and Guidance Federal Regulation & Guidance
key Other Useful Links
CHR Member Information CHR Member Information
whats new? What's New

THE HUMAN RESEARCH PROTECTION PROGRAM

THE COMMITTEE ON HUMAN RESEARCH

APPLYING TO THE CHR

CATEGORIES OF MODIFICATIONS (Revised February 2005, July 2006)

The principal investigator should evaluate whether a modification is major, minor, or administrative, using the definitions and tables of examples below. The determination depends on whether risks to participants are increased and the complexity of the changes. Major modifications require more copies and more intensive review than minor or administrative modifications. For questions about what kind of modification you have, please call the CHR office at 476-1814 and ask to be connected with a specialist handling modification requests or contact us.
Additional information is available at General Instructions: Modification Request.

Definitions
(examples follow below)

  • Major Modifications to previously approved research are changes in which
    • Any increase in risk to participants is more than minimal
      (See definition of Minimal Risk.)
    • or
    • any additional activity or procedure would not be eligible for
      expedited review
      if submitted as part of new research
    • or
    • the research itself involves more than minimal risks and the changes significantly alter the study design.

  • Minor Modifications to previously approved research are changes in which
    • any increase in risk to participants is no more than minimal risk
    • and
    • all additional activities or procedures would be eligible for review using the expedited procedures if submitted as part of new research
    • and
    • either the research itself involves minimal risks or the changes do not significantly alter the study design.

  • Administrative Modifications are Minor Modifications that do not affect study participants (subjects) in any way.

Important Note: If reasonable reviewers may differ on what category applies (e.g., on whether a change increases risks so they are more than minimal) the application should be submitted for the more stringent level of review.

Examples of types of modifications follow below:

FOR STUDIES THAT INITIALLY REQUIRED FULL COMMITTEE REVIEW

EXAMPLES OF MAJOR MODIFICATIONS
for studies that initally require full committee review
  • Changing, adding, or deleting drugs, devices, or other treatments being studied (significant alteration of design of study) (however, substituting approved drugs, devices, or other standard treatments that are being used in standard ways may be a minor modification if risks clearly are not increased)


  • Adding or deleting major procedures or diagnostic tests (e.g., adding bronchoscopy or spinal tap; doubling duration of treatment; deleting adjuvant chemotherapy; deleting diagnostic MRI or liver function test)


  • Increasing major risks or discomforts (e.g., risks from new procedures, deleted safety measures, or newly discovered serious risks; risks that are serious by themselves do not become minor even if subjects already have a terminal disease)


  • Changing study design (e.g., eliminating 1 arm of a multi-arm study or going from placebo-controlled to open-label; call CHR office to discuss whether a new application is more appropriate than a modification)


  • Adding serious privacy risks (e.g., asking participants about abusive behavior or current illegal activities)


  • Adding vulnerable populations (e.g., minors, prisoners, patients unable to consent)


  • Re-starting study after a hold for safety concerns


  • If sponsor or cooperative group specifically requires full committee review


  • Changing Principal Investigator in some circumstances. See Changing or Adding Investigators or Other Personnel.

Requirements:

Type of Review:

  • Reviewed by full committee


  • Approval letter sent when approved


  • New expiration date is usually given
EXAMPLES OF MINOR MODIFICATIONS
(except for Administrative Modifications) for studies that initially required full committee review
  • Changing minor procedures (e.g., adding small-volume blood draws, ultrasounds, visits with noninvasive procedures)


  • Reducing risks


  • Adding minor risks (e.g., risks of small blood draws)


  • Changing wording in CHR consent form, application, or other documents


  • Revising questionnaires (modification is major if the new questions are more likely than the old ones to evoke responses that would reasonably place subjects at risk of criminal or civil liability or be damaging to the subjects' financial standing, employability, insurability, reputation, or be stigmatizing if the answers became known outside of the study context)


  • Adding or changing advertisements or notices


  • Changing or deviating from entry criteria if the change creates no serious risks to participants


  • Changing the Co-Principal Investigator or other Key Personnel in some circumstances. See Changing or Adding Investigators or Other Personnel.

 

Requirements:

Type of Review:

  • Reviewed by a subcommittee (using “expedited” review procedures)


  • Approval letter sent when approved


  • New expiration date is not given
EXAMPLES OF ADMINISTRATIVE MODIFICATIONS
for studies that initially required full committee review
  • Changing procedures that do not affect participants (e.g., method of shipping samples)


  • Fixing typographical, grammatical, or spelling errors


  • Changing personnel (but PI and Co-PI stay the same) if no participant-contact documents are affected. See Changing or Adding Investigators or Other Personnel.


  • Not changing procedures that affect participants


  • Not changing risks


  • Not changing information on the CHR application form or protocol beyond fixing typographical, grammatical, formatting, or spelling errors


  • Not changing CHR consent form beyond fixing typographical, grammatical, formatting, or spelling errors

Requirements:

Type of Review:

  • Noted and filed


  • No approval letter sent

FOR STUDIES THAT INITIALLY REQUIRED EXPEDITED REVIEW

EXAMPLES OF MAJOR MODIFICATIONS for studies that initially required expedited review - WITH CHANGE THAT NOW REQUIRES FULL COMMITTEE REVIEW
  • Any change that:


  • Examples of changes that do not fit expedited review categories:
    • Adding invasive procedures other than small-volume blood draws


    • Adding use of experimental drugs or devices


    • Adding serious privacy risks (e.g., asking participants about abusive behavior or current illegal activities)


    • Revising questionnaires if the new questions are more likely than the old ones to evoke responses that would reasonably place subjects at risk of criminal or civil liability or be damaging to the subjects' financial standing, employability, insurability, reputation, or be stigmatizing if the answers became known outside of the study context


    • Changing retrospective record review of standard care to randomized test of two standard regimens

Requirements:

Study is no longer eligible for expedited review.

Type of Review:

  • Reviewed by full committee


  • Approval letter sent when approved


  • New expiration date is usually given
EXAMPLES OF MINOR MODIFICATIONS (except for Administrative Modifications) for studies that initially required expedited review (MAY INCLUDE SIGNIFICANT CHANGES IF STILL ELIGIBLE FOR EXPEDITED REVIEW)
  • Changing major procedures or activities without adding more-than-minimal risks (e.g., adding participant contact to a record-review study, adding a new round of participant contact and interviews, changing from review of past patients’ records to review of current patients’ records)


  • Changing study design without adding more-than-minimal risks (but changes in study purpose or changes in basic study design are usually best submitted as new studies, in order to avoid complexity, confusion, and delayed approval)


  • Changing method of contacting participants (e.g., from talking to PI’s patients to sending letters to patients ID’d through medical records)


  • Changing, adding, or deleting approved drugs, devices, or other standard treatments that are being used in standard ways


  • Adding vulnerable populations (e.g., minors, patients unable to consent) as long as risks remain minimal and other criteria for expedited review are still met. Adding prisoners is almost always a major modification requiring full committee review


  • Changing wording in CHR consent form, application, or other documents


  • Changing or adding questionnaires or other study instruments (but the study should be submitted for full committee review if the new questions are more likely than the old ones to evoke responses that would reasonably place subjects at risk of criminal or civil liability or be damaging to the subjects' financial standing, employability, insurability, reputation, or be stigmatizing if the answers became known outside of the study context)


  • Adding or changing advertisements or notices


  • Changing or deviating from entry criteria if the change itself creates no more than minimal risks to participants


  • Changing Principal Investigator, Co-PI, or other Key Personnel in some circumstances. See Changing or Adding Investigators or Other Personnel.

Requirements:

Type of Review:

  • Reviewed by a subcommittee (using “expedited” review procedures)


  • Approval letter sent when approved


  • New expiration date is not given
EXAMPLES OF ADMINISTRATIVE MODIFICATIONS for studies that initially required expedited review
  • Changing procedures that do not affect participants (e.g., method of shipping samples)


  • Fixing typographical, grammatical, or spelling errors


  • Changing personnel (but PI and Co-PI stay the same) if no participant-contact documents are affected See Changing or Adding Investigators or Other Personnel


  • Not changing procedures that affect participants


  • Not changing risks


  • Not changing CHR consent form beyond fixing typographical, grammatical, formatting, or spelling errors

Requirements:

Type of Review:

  • Noted and filed


  • No approval letter sent

Important Note: If a CHR member reviewing a "minor" or “administrative” modification request feels that it is too substantive to receive this type of review, the application will be referred for a higher level of review.